Click HereTherapeutic Options: Medicines not on the QTdrugs List
Attention All Commercial Users of QTdrugs Technology
Commercial use or reproduction of the QTdrugs list or other copyrighted content from the CredibleMeds® website is prohibited unless licensed or authorized by AZCERT, Inc. Commercial use by a company's employee(s) or contractor(s) is defined in AZCERT's Terms of Use.
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
Online orders for licenses can be placed here and quotes for licensing fees are available by contacting info@azcert.org.
In the early days of the COVID-19 pandemic, several drugs already on the market were widely touted as potentially effective and were often prescribed in the hope that they could alter the course of COVID-19. Many of those drugs were originally…
Merriam-Webster defines contraindicated as “not advised as a course of treatment or procedure” but the definition fails to address who or what type of organization/agency should have the authority to decide if a treatment is contraindicated under…
A century ago, Drs. Bazett and Fridericia separately and simultaneously published their recommendations for how to correct the QT interval for differences in heart rate. Bazett recommended dividing the QT by the square root of the heart rate…
Health screening is an established component of high-quality medical care and doctors regularly screen their patients for disease risk markers such as high cholesterol or hypertension. Yet, little progress has been made in finding ways to prevent…
In the last 9 months, over 153,000 unique visitors from 174 countries have accessed the CredibleMeds® website. This represents a 29 increase and 48% of visitors are from outside the U.S.
Using the list of QT prolonging drugs from the CredibleMeds website and patient information in the electronic health records, the CDSS automatically generated a risk score for QT prolongation and issued alerts to pharmacists (high risk or moderate…
Nelfinavir (Viracept®) and Ivabradine (Procoralan®, Coralan®, Corlentor®, Coraxan®, Ivabid®, Bradia®) have been added to the list of medicines with Conditional Risk of Torsades de Pointes (TdP).
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
